📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
In 2024, Apotea Sverige completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Apotea Sverige has also provided a category-level breakdown for 5 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Apotea Sverige’s data sources below and access millions more through our Disclosure Search.
In 2024, the total operational greenhouse gas (GHG) emissions ofApotea Sverige amounted to49.9metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Apotea Sverigedecreased by 5.31%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2024, the total Scope 1 emissions of Apotea Sverige were 0.1 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Compared to the previous year(2023), Apotea Sverige's Scope 1 emissions decreased by 50%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2024, Apotea Sverige reported Scope 2 greenhouse gas (GHG) emissions of 18 tCOâ‚‚e using the market-based method and 49.8 tCOâ‚‚e using the location-based method.a
Compared to the previous year(2023), Apotea Sverige's Scope 2 emissions(Location-Based) have remained relatively stable, indicating that Apotea Sverige's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2024, Apotea Sverige reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2024, Apotea Sverige reported 163,928 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Apotea Sverige includes a breakdown across 5of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Apotea Sverige reported total Scope 3 emissions of 163,928 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 100%of these emissions originated from upstream activities such as purchased goods and capital goods, while 0%came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2023), Apotea Sverige's Scope 3 emissions increased by 26.44%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2024, Apotea Sverige reported emissions for 5 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2024, the largest contributors to Apotea Sverige's Scope 3 emissions were:a
In 2024, Apotea Sverige reported Scope 1 greenhouse gas (GHG) emissions of 0.1 tCOâ‚‚e and total revenues of USD 500 millions. This translates into an emissions intensity of 0 tCOâ‚‚e per millions USD.a
In 2024, Apotea Sverige reported a Scope 1 emissions intensity of 0 tCOâ‚‚e per millions USD. Compared to the peer group median of 1.71, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2024, Apotea Sverige ranked 1 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
This places Apotea Sverige among the top performers, with one of the lowest emissions intensities relative to peers.a
In 2024, Apotea Sverige reported a total carbon footprint of 163,977.9 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 26.43% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Apotea Sverige's total carbon footprint was Scope 3 emissions, accounting for 99.97% of the company's total carbon footprint, followed by Scope 2 emissions at 0.03%.a